Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 3 Study of ZSP1273 in Otherwise Healthy Children 2-11 Years Old With Influenza A

NCT07229807 is registered in ClinicalTrials.gov with Guangdong Raynovent Biotech Co., Ltd as lead sponsor.

NCT NCT07229807
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07229807 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 3 Study of ZSP1273 in Otherwise Healthy Children 2-11 Years Old With Influenza A
Lead sponsor
Guangdong Raynovent Biotech Co., Ltd
Phase
Phase 3
Overall status
Active, not recruiting
Start date
November 22, 2025
Completion date
December 31, 2025
Enrollment
119 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

influenza a